03-Nov-2014 - Polyplus-transfection SA

Polyplus-transfection and Blue Sky BioServices sign a research and commercial license agreement for use of PEI-based transfection technologies

Polyplus-transfection SA and Blue Sky BioServices announced a non-exclusive, research and commercial license agreement. Polyplus has granted Blue Sky BioServices a licence to use Polyethylenimine (PEI) for in vitro transfection applications.

Blue Sky BioServices, has become the 17th sub-licensee, and the 4th CRO to acquire rights from Polyplus to use its PEI-mediated transfection applications for research and commercial purposes. Financial terms were not disclosed.

Facts, background information, dossiers
  • Polyplus-transfection
  • Blue Sky BioServices
  • polyethylenimine
More about Polyplus-transfection